Second Sight Medical (EYES) Q4 Revenues Beat Views
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Second Sight Reports Fourth Quarter and Full Year 2017 Financial Results
March 7, 2018 4:05 PM EST-- Year-over-year net sales in 2017 double to $8 million, driven by record implant volume --
SYLMAR, Calif.--(BUSINESS WIRE)-- Second Sight Medical Products, Inc. (NASDAQ: EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision to blind patients, today reported financial results for the three- and twelve-month periods ended December 31, 2017.
Recent Company Highlights:
Generated net sales of $3.1 million in the fourth quarter of 2017 and $8.0 million for the full year, compared to... More


